IP Library Granted Patent US 10,401,295
Granted Patent B2
US 10,401,295 · App. 15/313,580 · Granted Sep 3, 2019

Composition and method for monitoring lipid

Inventors: Prakrit Jena (New York, NY); Daniel A. Heller (New York, NY); Daniel Roxbury (New York, NY)
Assignee: Memorial Sloan Kettering Cancer Center
G01N21/6489A61B5/1455A61B5/14546B82Y5/00B82Y15/00B82Y30/00G01N21/6486G01N21/6428
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,401,295
App. No.
15/313,580
Granted
Sep 3, 2019
Kind
B2
Abstract

A method of detecting a condition in a subject comprises the steps of contacting cells of the subject with single-walled carbon nanotubes (SWCNTs), monitoring photoluminescence emitted by SWCNTs internalized into the cells and generating an SWCNT emission profile, comparing the SWCNT emission profile to a control emission profile for the SWCNTs to produce a result, and determining a likelihood of having the condition in the subject based on the result from the comparing step. Also disclosed is a method for screening agents capable of changing endocytic environment using SWCNTs.

Claims (5)

1. A method of detecting elevated lysosomal lipid content in in vitro HeLa cells using single-walled carbon nanotubes (SWCNTs), comprising:

contacting the HeLa cells in vitro with SWCNTs, wherein said contacting provides SWCNTs internalized into said cells;

monitoring photoluminescence emitted by SWCNTs internalized into said cells and generating an SWCNT emission profile;

wherein elevated lysosomal lipid content is detected upon a blue-shift in the SWCNT emission profile from a control emission profile; and

wherein the SWCNTs are purified (8,6) SWCNTs encapsulated with ss(GT) 6 oligonucleotides.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA FOR PRAKRIT JENA PREVIOUSLY RECORDED ON REEL 041341 FRAME 0909. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT SPELLING OF PAKRIT JENA'S NAME IS PRAKRIT JENA. Recorded Mar 8, 2017
From: JENA, PRAKRIT; HELLER, DANIEL A.; ROXBURY, DANIEL
To: MEMORIAL SLOAN-KETTERING CANCER CENTER
Reel/Frame 041911/0169 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2017
From: JENA, PAKRIT; HELLER, DANIEL A.; ROXBURY, DANIEL
To: MEMORIAL SLOAN-KETTERING CANCER CENTER
Reel/Frame 041341/0909 →
CONFIRMATORY LICENSE Recorded Jan 4, 2017
From: SLOAN-KETTERING INST CAN RESEARCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041239/0491 →
Continuity (2)
Provisional Application 62004122 · May 28, 2014
Related Publication 20170199126A1 · Jul 13, 2017